anti-inflammatoty and immuno-therapy living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID-19 severe or critically

	COVID 19 outpatients
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies
colchicine	PRINCIPLE ... COLCORONA
corticosteroids
ciclesonide	Clemency Ezer N ...
Immunostimulants drugs
convalescent plasma treatment	C3PO CONV-ERT CoV-Early ...
Early convalescent plasma.	CoV-Early ...
interferon
inhaled interferon
SNG001 inhaled interferon beta	ACTIV-2 SNG001
peginterferon	TOGETHER interferon lambda Feld
neutralizing antibody
amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences)	ACTIV-2 ...
bamlanivimab monotherapy	OPTIMISE-C19 ... BLAZE-1 phase 2 ...
bamlanivimab/etesevimab	OPTIMISE-C19 ... BLAZE-4 BLAZE-1 phase 2 ... BLAZE-1 phase 3 ...
Bebtelovimab (LY-CoV1404)	BLAZE 4 LY-CoV1404
casirivimab/imdevimab (Ronapreve)	Cov-2067 Weinreich ... Cov-2069 ... Mazzotta
cilgavimab and tixagevimab (Evusheld)	TACKLE
regdanvimab (Regkirona- CT-P59-Celltrion)	CT-P59 3.2 part 1 CT-P59 3.2 part 2
sotrovimab (Xevudy; VIR-7831)	COMET-ICE
inhaled corticosteroids
budesonide	PRINCIPLE STOIC